Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$444M |
| 2 |
Workday
WDAY
|
+$364M |
| 3 |
AbbVie
ABBV
|
+$340M |
| 4 |
Advanced Micro Devices
AMD
|
+$312M |
| 5 |
Synopsys
SNPS
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$1.81B |
| 2 |
Apple
AAPL
|
+$947M |
| 3 |
Boston Scientific
BSX
|
+$628M |
| 4 |
Microsoft
MSFT
|
+$585M |
| 5 |
Netflix
NFLX
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Prologis
PLD
$138B
| $330M | 0.16% |
2,045,397
+39,270
| +2% | +$5.99M |
|
152
Cboe Global Markets
CBOE
$31.1B
| $328M | 0.16% |
2,868,681
+2,105
| +0.1% | +$249K |
|
153
Tesla
TSLA
$1.22T
| $321M | 0.16% |
894,714
-464,727
| -34% | -$145M |
|
154
Elanco Animal Health
ELAN
$13B
| $321M | 0.16% |
12,311,871
+715,654
| +6% | +$19.1M |
|
|
BHVN
155
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $321M | 0.15% |
2,706,152
+1,299,597
| +92% | +$162M |
|
156
Estee Lauder
EL
$30.6B
| $318M | 0.15% |
1,165,827
-71,605
| -6% | -$21.5M |
|
157
Gilead Sciences
GILD
$166B
| $316M | 0.15% |
5,315,286
-22,544
| -0.4% | -$1.44M |
|
158
VICI Properties
VICI
$29.9B
| $310M | 0.15% |
10,899,723
-1,588,477
| -13% | -$44.5M |
|
159
Autodesk
ADSK
$51B
| $299M | 0.14% |
1,395,486
-1,555,101
| -53% | -$358M |
|
160
Novartis
NVS
$303B
| $297M | 0.14% |
3,380,885
-178,294
| -5% | -$15.4M |
|
161
Tyler Technologies
TYL
$13.6B
| $291M | 0.14% |
653,660
+2,134
| +0.3% | +$959K |
|
162
Corning
GLW
$104B
| $290M | 0.14% |
7,860,908
-200,615
| -2% | -$7.83M |
|
163
Centene
CNC
$30.7B
| $287M | 0.14% |
3,414,610
-181,263
| -5% | -$14.9M |
|
164
West Pharmaceutical
WST
$23.7B
| $283M | 0.14% |
688,398
-190,464
| -22% | -$74.6M |
|
165
Icon
ICLR
$14B
| $282M | 0.14% |
1,160,950
-1,184,771
| -51% | -$297M |
|
166
Canadian Natural Resources
CNQ
$92.6B
| $280M | 0.14% |
9,229,452
-1,684,023
| -15% | -$44.9M |
|
167
Cisco
CSCO
$461B
| $280M | 0.14% |
5,023,579
-115,270
| -2% | -$6.52M |
|
168
Snowflake
SNOW
$95.2B
| $279M | 0.13% |
1,217,676
+174,461
| +17% | +$45.1M |
|
169
Johnson & Johnson
JNJ
$649B
| $275M | 0.13% |
1,554,209
+15,414
| +1% | +$2.62M |
|
170
Unity
U
$13.6B
| $275M | 0.13% |
2,775,196
+506,957
| +22% | +$52.5M |
|
171
AstraZeneca
AZN
$267B
| $274M | 0.13% |
2,067,338
-1,252,200
| -38% | -$150M |
|
172
Regal Rexnord
RRX
$13.6B
| $273M | 0.13% |
1,838,109
-401,955
| -18% | -$64.4M |
|
173
CVS Health
CVS
$138B
| $273M | 0.13% |
2,696,863
-548,607
| -17% | -$57.6M |
|
174
Goldman Sachs
GS
$308B
| $271M | 0.13% |
821,021
+375,103
| +84% | +$132M |
|
175
ResMed
RMD
$30.3B
| $269M | 0.13% |
1,108,015
-216,416
| -16% | -$52.3M |
|
Similar funds
Janus Henderson Group's Q1 2022 Portfolio in Review
As of Q1 2022, Janus Henderson Group held 2,774 positions worth $207B, down 14% from $240B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group withdrew a net $13B in Q1 2022, closing 135 positions and reducing 1,078 holdings. Its most notable exit was Xilinx Inc, an estimated $378M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Janus Henderson Group opened a new position in Tricon Residential Inc. worth $36M.
- Janus Henderson Group's largest Q1 2022 buy was Tricon Residential Inc.: 2,264,492 shares worth $36M.
- Janus Henderson Group added most to Atlassian in Q1 2022, an estimated $444M increase.
- Janus Henderson Group's biggest Q1 2022 reduction was Adobe, cutting an estimated $1.81B.
- Janus Henderson Group fully exited Xilinx Inc in Q1 2022, selling an estimated $378M.
- Janus Henderson Group's ten largest holdings make up 25% of its $207B portfolio in Q1 2022.
- Janus Henderson Group opened 230 new positions and closed 135 in Q1 2022.
- Janus Henderson Group's portfolio value fell 14% quarter-over-quarter to $207B.
Based on Janus Henderson Group's 13F filing for Q1 2022, filed 16 May 2022.